MS Bio (0013Y0), a regenerative medicine platform company that develops products based on human tissue, is trading up more than 70% from its initial public offering price on its first day on the KOSDAQ.
As of 9:22 a.m. on the 22nd, MS Bio was quoted at 13,610 won, up 74.49% from its IPO price of 7,800 won, according to the Korea Exchange. The stock opened at 16,000 won, more than double the offering price, but failed to extend gains as profit-taking emerged immediately after listing, leaving the shares on a downward path. That marks a decline of about 15% from the opening price.
MS Bio conducted bookbuilding with institutional investors from Sept. 28 through Oct. 2, setting the IPO price at 7,800 won, the top of its indicative range of 6,800 won to 7,800 won. Based on shares subscribed, 30.6% of institutional investors pledged not to sell their MS Bio shares for at least 15 days after listing. That is the second-highest lockup commitment ratio among companies that have completed KOSDAQ offerings since September, after Melcon at 36.07%.
Founded in 2015, MS Bio develops and manufactures medical products that use human tissue and biomaterials to aid regeneration of skin and bone. It supplies products to medical fields that require tissue regeneration and restoration. Last year it posted revenue of 23.787 billion won and operating profit of 8.558 billion won. Operating profit rose about 42.9% from 5.99 billion won in 2024.
The company plans to use proceeds from the listing to build a new plant in Ochang, North Chungcheong Province, expand production facilities and establish a base for overseas operations. It aims to strengthen its competitiveness in the global regenerative medicine market by expanding overseas footholds in markets including the United States and Vietnam and by pursuing clinical trials and commercialization of new products.
Elice Group, which tumbled more than 30% below its IPO price on its first trading day, rose for a second consecutive session. The stock climbed as high as 92,300 won during the session, topping its IPO price of 90,500 won for the first time since listing. It later eased as some investors took profits, trading at around 89,400 won, up 12.14%.
